← FDA Drug Approvals (Drugs@FDA)

ABACAVIR AND LAMIVUDINE

NDA · New Drug Application · Sponsor: CIPLA LIMITED · Approved 2017-04-06

Drug application

FDA Application #

NDA208775

Application type

New Drug Application

Brand name

ABACAVIR AND LAMIVUDINE

Generic name

Abacavir

Active ingredients

ABACAVIR; LAMIVUDINE

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

CIPLA LIMITED

First approval

2017-04-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown